XML 21 R9.htm IDEA: XBRL DOCUMENT
v3.23.1

INTANGIBLE ASSETS | 3 Months Ended
--- | ---
Mar. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract] |
INTANGIBLE ASSETS | NOTE 3. INTANGIBLE ASSETS As of March 31, 2023, the Company’s intangible assets consisted of: SCHEDULE OF FINITE LIVED INTANGIBLE ASSETS
Definite lived intangible assets |  |  |
Balance at December 31, 2022 |  | $ | 379,686 |
Amortization |  |  | (42,188 | )
Balance at March 31, 2023 |  | $ | 337,498 |
For identified definite lived intangible assets, there was no impairment expense during the three months ended March 31, 2023 and 2022. For identified definite lived intangible assets, amortization expense amounted to $42,188 during the three months ended March 31, 2023 and 2022. ENVERIC BIOSCIENCES, INC. AND SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for all or part of the information related to intangible assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//350-30/tableOfContent + Details
Name: | us-gaap_IntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration